XBP1 and ovarian carcinoma: For example, IRE1α-XBP1 over-activation in dendritic cells could disrupt the lipid metabolic homeostasis and cripple antigen presentation to T cells, thereby impeding the protective immune responses against tumor cells in ovarian cancer [59].